Investing.com - Proto Labs (NYSE: PRLB) reported first quarter EPS of $0.40, $0.08 better than the analyst estimate of $0.32. Revenue for the quarter came in at $127.9M versus the consensus estimate of $125.53M.
Guidance
Proto Labs sees Q2 2024 EPS of $0.30-$0.38 versus the analyst consensus of $0.39.
Proto Labs sees Q2 2024 revenue of $122.00M-$130.00M versus the analyst consensus of $128.30M.
Proto Labs's stock price closed at $31.14. It is down -15.52% in the last 3 months and up 11.10% in the last 12 months.
Proto Labs saw 0 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Proto Labs's stock price’s past reactions to earnings here.
According to InvestingPro, Proto Labs's Financial Health score is "fair performance".
Check out Proto Labs's recent earnings performance, and Proto Labs's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar